tickstock newsroom AI
Articles
Oracle Power clears preliminary heritage survey at Northern Zone Gold Project
Preliminary report clears three tenements 25 km east of Kalgoorlie, removing a key hurdle to the Mine Development and Closure Plan and supporting an imminent mining‑lease conversion.
Renalytix expands testing capacity 3.5x and submits CE technical file for kidneyintelX.dkd
Renalytix has moved its assay operations into a new New York laboratory that boosts capacity to more than 100,000 tests a year, cuts fixed costs (NPV savings of $2.6m over five years) and, separately, has completed submission of the CE marking technical file for kidneyintelX.dkd.
Transense installs die-bonder to scale SAWsense production
Transense Technologies has invested £0.4m in a high-precision die bonding machine, taking pilot line capital spend to over £1m as it moves SAWsense from development toward high-volume manufacturing.
Roundhouse Digital secures ETH‑backed loan
Roundhouse Digital has agreed a loan facility secured against part of its Ethereum treasury to free up working capital while keeping exposure to its crypto holdings.
The Premarket Brief: Ferrexpo eyes equity raise as cash runs dry, Reckitt Benckiser, Bunzl, Senior, Shoe Zone, hVIVO, Cerillion, Fresnillo
A busy morning of corporate updates lands with a cautious tone across UK equities, with a distressed mining group flagging a liquidity cliff, a consumer goods giant navigating a patchy recovery, and a footwear retailer reversing into loss territory. The macro backdrop remains tense, with the Federal
Pulsar Helium secures 488,090-acre Michigan helium exploration option
Shoe Zone warns of full-year loss due to weakening consumer confidence
Reckitt Benckiser holds 2026 outlook amid 'geopolitical disruption'
The consumer brands firm flagged margin pressure, and said that modelling a $110 oil scenario, it anticipates c.£130-150m of additional input costs.
Fresnillo reports lower Q1 silver and steady gold
Senior forecasts full-year trading comfortably ahead after strong Q1
Cerillion flags weaker H1 but says full-year expectations remain intact
Valereum swaps $200m note for VGOLD tokens in escrowed tokenisation deal
hVIVO to run pivotal Phase III whooping cough human challenge trial for ILiAD
hVIVO has signed a multi‑year contract to deliver the world's first pivotal Phase III human challenge trial for ILiAD Biotechnologies' intranasal BPZE1 vaccine, a study of more than 500 volunteers that should drive most revenue in 2026-27.
Bunzl reiterates 2026 guidance as Q1 trading holds steady
Underlying revenue rose 2.0% in the three months to 31 March and adjusted operating profit was in line with expectations, leaving full‑year guidance unchanged.
Ferrexpo reveals dwindling cash position, eyes equity raise
Ferrexpo said it is exploring a potential equity capital raise to plug working‑capital shortfalls after net accessible cash fell to roughly US$17m and the group warned liquidity will only last to “approximately the end of August 2026.”
Mining Today: Rio Tinto posts 9% copper-equivalent growth, Capital, Oriole Resources, Beowulf Mining
Mpac Group posts 42% revenue rise as acquisitions lift underlying profit
Mpac Group reported FY25 revenue up 42% and underlying operating profit up 51% for the year to 31 December 2025 as full-year contributions from CSi and BCA offset weaker OEM demand and kept results in line with market expectations.
World Chess narrows continuing loss as it shifts focus to online arena
Rapid Nutrition to acquire Australian wellness stores to build flagship DTC platform